共查询到19条相似文献,搜索用时 203 毫秒
1.
布鲁菌外膜蛋白Omp31原核表达及抗原性分析 总被引:1,自引:1,他引:0
克隆羊布鲁菌的外膜蛋白Omp31基因,在大肠埃希菌中表达、纯化,并对Omp31蛋白的抗原性进行分析。以羊布鲁菌的染色体DNA为模板,扩增Omp31基因,双酶切后克隆至pET32a上,在大肠埃希菌ER2566(DE3)中诱导表达,组氨酸结合树脂柱纯化,Western blot鉴定Omp31蛋白的抗原性。将Omp31克隆至载体pET32a,提取的重组质粒经PCR鉴定、双酶切鉴定和测序分析确定目的基因成功插入到了克隆载体中。将重组质粒转化于大肠埃希菌ER2566(DE3)中表达获得HIS融合蛋白,SDS-PAGE分析证明,表达产物为43 ku的融合蛋白。Western blot结果表明,表达的蛋白具有与布鲁菌外膜蛋白相同的抗原性。 相似文献
2.
3.
本试验旨在构建表达猪布鲁菌(Brucella suis)外膜蛋白Omp25蛋白的真核重组表达质粒,并探讨Omp25蛋白对猪肺泡巨噬细胞生长活性及细胞因子分泌的影响。以猪布鲁菌基因组DNA为模板,设计带有6×His标签的引物克隆Omp25基因,扩增产物克隆入pCI-neo真核表达载体,双酶切及测序鉴定正确后转染猪肺泡巨噬细胞3D4/21,检测其对巨噬细胞生长活性和分泌细胞因子的影响。RT-PCR和Western blotting检测结果证实Omp25蛋白获得正确表达。显微镜观察细胞形态表明,Omp25蛋白对猪肺泡巨噬细胞的形态无明显影响。MTT结果表明,Omp25蛋白对猪肺泡巨噬细胞的生长活性有轻度但不显著的抑制作用。ELISA检测TNF-α和IL-12蛋白表达水平表明,Omp25蛋白可以显著抑制巨噬细胞分泌TNF-α和IL-12。本试验成功构建了表达猪布鲁菌外膜蛋白Omp25蛋白的真核重组表达质粒,该蛋白对猪肺泡巨噬细胞的细胞形态没有明显影响,对其生长活性有轻度但不显著的抑制作用,可以显著抑制巨噬细胞分泌TNF-α和IL-12。 相似文献
4.
5.
《中国兽医学报》2019,(2):260-264
为提高布鲁菌疫苗株的免疫保护效果,本试验以牛布鲁菌疫苗株S19为研究对象,将羊布鲁菌Omp31基因克隆、扩增并插入至广宿主质粒pBBR1MCS-2中,构建重组质粒pBBR1MCS-Omp31;通过电转化的方式转入S19感受态细胞中,经抗性基因筛选和PCR验证,获得重组牛布鲁菌S19-Omp31株;该重组菌株连续传25代未发现重组质粒和Omp31基因丢失,表明其遗传稳定性良好;进一步经SDS-PAGE检测可见约26 000相对分子质量的目的条带,采用Western blot法检测显示目的蛋白可与His单克隆抗体及Omp31蛋白高免血清反应。本研究构建的重组牛布鲁菌S19-Omp31株能够稳定表达目的基因,为进一步开展S19-Omp31株的免疫效果评价奠定基础。 相似文献
6.
本试验旨在构建表达猪布鲁菌(Brucellasuis)外膜蛋白0mp25蛋白的真核重组表达质粒,并探讨Omp25蛋白对猪肺泡巨噬细胞生长活性及细胞因子分泌的影响。以猪布鲁菌基因组DNA为模板,设计带有6×His标签的引物克隆Orap25基因,扩增产物克隆入pCI-neo真核表达载体,双酶切及测序鉴定正确后转染猪肺泡巨噬细胞3D4/21,检测其对巨噬细胞生长活性和分泌细胞因子的影响。RT—PCR和Westernblotting检测结果证实Omp25蛋白获得正确表达。显微镜观察细胞形态表明,Omp25蛋白对猪肺泡巨噬细胞的形态无明显影响。MTT结果表明,Orap25蛋白对猪肺泡巨噬细胞的生长活性有轻度但不显著的抑制作用。ELISA检测TNF—α和IL-12蛋白表达水平表明,Omp25蛋白可以显著抑制巨噬细胞分泌TNF-α和IL-12。本试验成功构建了表达猪布鲁菌外膜蛋白Omp25蛋白的真核重组表达质粒,该蛋白对猪肺泡巨噬细胞的细胞形态没有明显影响,对其生长活性有轻度但不显著的抑制作用,可以显著抑制巨噬细胞分泌TNF—α和IL-12。 相似文献
7.
8.
获得高纯度具有生物学活性的重组布鲁菌Omp10、Omp25融合蛋白,并进行抗原性的分析。将用PCR扩增出的布鲁菌Omp10、Omp25基因片段分别克隆到原核表达载体pET-32α中,构建pET-32α-Omp10/Omp25原核表达质粒。将其转入大肠杆菌BL21(DE3)PlysS中,用IPTG诱导表达,经HisTrap HP亲和层析柱分离纯化,分别用Western-blot和间接ELISA检测产物的抗原性。基因测序及酶切鉴定证明pET-32α-Omp10/Omp25原核表达载体构建成功。SDS-PAGE表明,Omp10、Omp25融合蛋白均以包涵体的形式在大肠杆菌中高效表达。经过包涵体的变性、复性及亲和层析纯化,成功获得了大小分别为34 000和44 000的融合蛋白,与预测的相对蛋白分子质量一致。Western和间接ELISA试验证明纯化的Omp10、Omp25融合蛋白能被免疫的牛布鲁菌阳性血清所识别。结果表明,成功获得了布鲁菌Omp10、Omp25融合蛋白,且均具有一定的免疫原性,通过血清学反应证实,Omp10、Omp25蛋白为布鲁菌病临床诊断试剂盒的研制奠定了基础。 相似文献
9.
11.
Attenuation of a Brucella abortus mutant lacking a major 25 kDa outer membrane protein in cattle 总被引:7,自引:0,他引:7
Edmonds MD Cloeckaert A Booth NJ Fulton WT Hagius SD Walker JV Elzer PH 《American journal of veterinary research》2001,62(9):1461-1466
OBJECTIVE: To determine the virulence of a Brucella abortus mutant, BA25, lacking a major 25 kd outer membrane protein (Omp25) in cattle. ANIMALS: 20 mixed-breed heifers in late gestation. PROCEDURE: 10 heifers were inoculated with 1 x 10(7) colony-forming units of the Omp25 mutant via the conjunctival sac, and an equal number were infected with the virulent parental strain B. abortus 2308. The delivery status of the dams was recorded, and colonization was assessed following necropsy. The ability of BA25 to replicate inside bovine phagocytes and chorionic trophoblasts was also evaluated in vitro because of the propensity of virulent brucellae to replicate inside these cells in vivo. RESULTS: The parental strain induced abortions in 5 of 10 inoculated cattle, whereas only 1 of 10 dams exposed to BA25 aborted. Brucella abortus strain 2308 colonized all of the cow-calf pairs and induced Brucella-specific antibodies in 100% of the dams. In contrast, BA25 was isolated by bacteriologic cultural technique from 30% of the calves and 50% of the inoculated dams (n = 10). Of the 10 heifers inoculated with BA25, 4 did not develop Brucella-specific antibodies nor were they colonized by the mutant strain. In bovine macrophages and chorionic trophoblasts, BA25 replicated in significantly lower numbers than the virulent parental strain (n = 3). CONCLUSIONS AND CLINICAL RELEVANCE: The 25 kd outer membrane protein may be an important virulence factor for B. abortus in cattle. The attenuation of the Omp25 mutant in cattle may involve the inability of BA25 to replicate efficiently in bovine phagocytes and chorionic trophoblasts. 相似文献
12.
Major outer membrane proteins of Brucella spp.: past,present and future 总被引:16,自引:0,他引:16
The major outer membrane proteins (OMPs) of Brucella spp. were initially identified in the early 1980s and characterised as potential immunogenic and protective antigens. They were classified according to their apparent molecular mass as 36–38 kDa OMPs or group 2 porin proteins and 31–34 and 25–27 kDa OMPs which belong to the group 3 proteins. The genes encoding the group 2 porin proteins were identified in the late 1980s and consist of two genes, omp2a and omp2b, which are closely linked in the Brucella genome, and which share a great degree of identity (>85%). In the 1990s, two genes were identified coding for the group 3 proteins and were named omp25 and omp31. The predicted amino acid sequences of omp25 and omp31 share 34% identity. The recent release of the genome sequence of B. melitensis 16 M has revealed the presence of five additional gene products homologous to Omp25 and Omp31. The use of recombinant protein technology and monoclonal antibodies (MAbs) has shown that the major OMPs appear to be of little relevance as antigens in smooth (S) B. abortus or B. melitensis infections i.e. low or no protective activity in the mouse model of infection and low or no immunogenicity during host infection. However, group 3 proteins, in particular Omp31, appear as immunodominant antigen in the course of rough (R) B. ovis infection in rams and as important protective antigen in the B. ovis mouse model of infection. The major OMP genes display diversity and specific markers have been identified for Brucella species, biovars, and strains, including the recent marine mammal Brucella isolates for which new species names have been proposed. Recently, Omp25 has been shown to be involved in virulence of B. melitensis, B. abortus and B. ovis. Mutants lacking Omp25 are indeed attenuated in animal models of infection, and moreover provide levels of protection similar or better than currently used attenuated vaccine strain B. melitensis Rev.1. Therefore, these mutant strains appear interesting vaccine candidates for the future. The other group 3 proteins identified in the genome merit also further investigation related to the development of new vaccines. 相似文献
13.
本试验旨在克隆布鲁氏菌外膜蛋白2b(Omp2b)基因并进行原核表达和蛋白的生物信息学分析。根据布鲁氏菌M5-90株外膜蛋白Omp2b基因序列设计引物,以布鲁氏菌基因组为模板,通过PCR技术扩增得到Omp2b基因片段,回收纯化后,将此片段连接入pMD20-T质粒,将该重组质粒转化E.coli DH5α感受态细胞,挑取阳性克隆菌提取质粒后,送公司测序。将该片段亚克隆入pET28a载体,构建pET28a-Omp2b表达载体,转化E.coli BL21(DE3)菌株,IPTG诱导其表达,用SDS-PAGE和Western blotting分析鉴定此蛋白。运用DNAMAN、BioEdit等各种工具软件对Omp2b基因编码的氨基酸序列进行分析。结果显示,成功克隆了Omp2b基因,其开放阅读框为1041 bp,编码347个氨基酸;构建了pET28a-Omp2b原核表达载体,并在E.coli BL21(DE3)中成功表达了Omp2b基因,表达蛋白约38 ku;Omp2b蛋白二级结构中α-螺旋、伸展链、β-折叠和无规卷曲分别占20.17%、26.22%、5.76%和47.84%。 相似文献
14.
布鲁氏菌表面抗原研究进展 总被引:5,自引:2,他引:3
布鲁氏菌表面最主要的抗原是脂多糖(LPS)和外膜蛋白(OMPs),R-LPS是R型布鲁氏菌主要的表面抗原,S型布鲁氏菌的S-LPS已被证明是一个主要的毒力因子,它的O链部分含有布鲁氏菌表面绝大多数的抗原位点,是一个很重要的保护性抗原;OMPs被认为是布鲁氏菌表面潜在的抗原结构,在光滑型布鲁氏菌表面,由于OMPs受到了LPS-O链的干扰,致使它的抗原性没有充分地表现出来,但在绵羊布鲁氏菌表面却出现了不同的情况。未来几年,对OMPs的研究将成为该领域的热点,尤其是对Omp25突变体的研究。 相似文献
15.
克隆了犬布氏杆菌外膜蛋白Omp31基因并构建原核表达系统,并对表达产物进行了初步的血清学鉴定。利用PCR技术扩增犬布氏杆菌RM6/66参考株Omp31基因,然后将其克隆到pGEMT-easy载体上进行测序。测序正确后,将该基因插入到pET-32a载体中构建原核表达载体,转化大肠杆菌BL21感受态细胞,诱导表达融合蛋白,Western blot分析融合蛋白的免疫反应性。结果构建了犬布氏杆菌Omp31基因的原核表达载体pET-Omp31,并且在大肠杆菌中成功表达融合蛋白,经Western Blot鉴定该蛋白能被犬布氏杆菌阳性血清所识别。犬布氏杆菌外膜蛋白Omp31的表达成功,为犬布氏杆菌病血清学诊断方法的建立提供了基础资料。 相似文献
16.
17.
Brucella species lacking the major outer membrane protein Omp25 are attenuated in mice and protect against Brucella melitensis and Brucella ovis 总被引:7,自引:0,他引:7
To aid in the development of novel efficacious vaccines against brucellosis, Omp25 was examined as a potential candidate. To determine the role of Omp25 in virulence, mutants were created with Brucella abortus (BA25), Brucella melitensis (BM25), and Brucella ovis (BO25) which contain disruptions in the omp25 gene (Deltaomp25 mutants). Western immunoblot analysis and PCR verified that the Omp25 protein was not expressed and that the omp25 gene was disrupted in each strain. BALB/c mice infected with B. abortus BA25 or B. melitensis BM25 showed a significant decrease in mean CFU/spleen at 18 and 4 weeks post-infection, respectively, when compared to the virulent parental strain (P<0.05, n=5). Mice infected with B. ovis BO25 had significantly lower mean CFU/spleen counts from 1 to 8 weeks post-infection, at which point the mutant was cleared from the spleens (P<0.01, n=5). Murine vaccination with either BM25 or the current caprine vaccine B. melitensis strain Rev. 1 resulted in more than a 2log(10) reduction in bacterial load following challenge with virulent B. melitensis (P<0.01, n=5). Vaccination of mice with the B. ovis mutant resulted in clearance of the challenge strain and provided 2.5log(10) greater protection against virulent B. ovis than vaccine strain Rev. 1. Based on these data, the B. melitensis and B. ovis Deltaomp25 mutants are interesting vaccine candidates that are currently under study in our laboratory for their safety and efficacy in small ruminants. 相似文献
18.
根据GenBank公布的羊布鲁氏菌(B.melitensis) M5-90株外膜蛋白(outer membrane protein,Omp)基因序列,设计1对引物,以其全基因组为模板,采用PCR技术对其进行扩增,得到381 bp的目的片段,连接入pMD20-T载体,转化E.coli DH5α感受态细胞;测序正确后,构建pET-28a-Omp10原核表达质粒,再将该质粒转化入E.coli BL21(DE3), IPTG诱导表达融合蛋白His-Omp10,用SDS-PAGE和Western blotting进行分析.结果表明, 成功构建了含Omp10基因的原核表达载体,并在E.coli BL21(DE3)中表达了Omp10基因,诱导得到的融合蛋白经鉴定与目的蛋白大小一致,证明Omp10得到成功表达.该试验为布鲁氏菌病的进一步研究奠定基础. 相似文献
19.
Pasteurella multocida A:3 is a major cause of bovine pneumonia. A major antigenic heat-modifiable 28kDa outer membrane protein (Omp28) was previously identified. The purpose of this study was to purify and characterize Omp28 immunologically and structurally. Omp28 was extracted from N-lauroylsarcosine-insoluble protein preparations by a combination of detergent fractionation with Zwittergent 3-14 and chromatography. Partial N-terminal amino acid sequence confirmed Omp28 as a member of the OmpA-porin family. However, porin activity could not be demonstrated in a lipid-bilayer assay. Heat modifiability of purified Omp28 was demonstrated, and Omp28 was found in outer membrane fraction of P. multocida. Surface exposure of Omp28 was demonstrated by partial protease digestion of intact bacteria, by binding of anti-Omp28 polyclonal ascites fluid to the bacterial surface, and by partial inhibition of anti-outer membrane antiserum binding by previous incubation of the bacteria with anti-Omp28 serum. CD-1 mice vaccinated with purified Omp28 developed a significant antibody titer (P<0.05) compared to the control treatment group but were not protected from a homologous intraperitoneal bacterial challenge. By contrast, treatment groups vaccinated with P. multocida outer membrane, formalin-killed P. multocida or a commercial vaccine were significantly protected from challenge. In vitro complement-mediated killing of P. multocida was observed in post-vaccination sera of outer membrane, formalin-killed P. multocida, and commercial vaccine-treatment groups, but not with sera from the Omp28-treatment group. In conclusion, although Omp28 is surface exposed and antigenic, it may not be a desirable immunogen for stimulating immunity to P. multocida. 相似文献